CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Compare ownership costs across dividend ETFs to identify which option offers the best balance of cost, yield, and risk.
22,825 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Scotiabank announces the acquisition of Maple Financial Holdings, owner of MapleMark Bank, to bolster its U.S. mortga...
The U.S. Treasury reaffirmed that no deals or guarantees with Iran are allowed for safe passage through the Strait of...
Ford reports a decisive narrowing of EV losses in Q1 2026, lifting full-year guidance and accelerating its energy bus...
Joby Aviation posted record Q4 2025 revenue driven by the Blade acquisition, but the stock remains volatile as cash b...
Nvidia sits at a pivotal crossroads as driverless technology could next reshape how auto tech and AI collide. This ar...
Old homes are cash machines for savvy flippers, but growing bureaucratic delays complicate rehab plans. Learn where r...
Bitcoin has moved back into a critical zone around $66,900 to $68,000, renewing questions about whether the price wil...
Big live events mix music with money. This guide breaks down how Ye’s Dutch concerts ahead can influence your budget,...
Investors are buzzing about Revolution Medicines this year as its RAS-focused cancer programs advance. This article l...
Bitcoin tumbled to $59,000 last Friday, the lowest in months, sparking a debate among traders about whether a bottom ...
Retirement isn’t about erasing your work life. It’s about selecting the best parts to carry forward. Here are 10 thin...